Melatonin—Aluminum Oxide—Polymethylsiloxane Complex on Apoptosis of Liver Cells in a Model of Obesity and Type 2 Diabetes Mellitus


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the effects of a melatonin—aluminum oxide—polymethylsiloxane complex (complex M) on the expression of apoptosis regulators Bcl-2 and Bad in the liver of homozygous db/db BKS.Cg-Dock7m+/+Leprdb/J mice with obesity and type 2 diabetes. Complex M or placebo was administered daily through the gastric tube during weeks 8-16 of life. In mice with type 2 diabetes mellitus receiving placebo, enhanced immunohistochemical reactions for proapoptotic Bad protein and weak response for anti-apoptotic Bcl-2 protein were observed. Administration of complex M shifted the ratio of apoptosis regulators: the area of Bcl-2 expression significantly increased and against the background of reduced Bad expression area. These findings attest to antiapoptotic effect of complex M in the liver on the model of type 2 diabetes mellitus.

About the authors

S. V. Michurina

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Author for correspondence.
Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

I. Yu. Ischenko

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

S. A. Arkhipov

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

V. V. Klimontov

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

M. A. Cherepanova

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

M. A. Korolev

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

L. N. Rachkovskaya

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

E. L. Zav’yalov

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk

V. I. Konenkov

Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science

Email: s.michurina@ngs.ru
Russian Federation, Novosibirsk


Copyright (c) 2017 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies